Esophageal & Gastric DisordersMay 6, 20265 min read

Q-Bank Breakdown: Barrett esophagus — Why Every Answer Choice Matters

Clinical vignette on Barrett esophagus. Explain correct answer, then systematically address each distractor. Tag: GI > Esophageal & Gastric Disorders.

Barrett esophagus is one of those “Step classics” that shows up in a deceptively simple way: a reflux story, a biopsy buzzword, and then a question that tests whether you can separate risk factors, histology, and management from a pile of tempting distractors. Let’s walk through a Q-bank-style vignette and then dismantle every answer choice like you’re reviewing with a friend after a long block.


The Vignette (GI > Esophageal & Gastric Disorders)

A 52-year-old man presents with years of heartburn and regurgitation, worse after meals and when lying down. He has central obesity and uses OTC antacids most days. He denies weight loss but notes intermittent dysphagia to solids over the past few months. Upper endoscopy shows salmon-colored mucosa extending proximally from the gastroesophageal junction. Biopsies reveal intestinal-type columnar epithelium with goblet cells.

Question: Which of the following is the most important long-term complication of this condition?

Answer choices

A. Squamous cell carcinoma of the esophagus
B. Esophageal adenocarcinoma
C. Esophageal varices
D. Mallory-Weiss tear
E. Achalasia due to loss of myenteric plexus neurons


The Correct Answer: B. Esophageal adenocarcinoma

Barrett esophagus is metaplasia of the distal esophagus: nonciliated, mucin-secreting columnar epithelium with goblet cells replaces normal stratified squamous epithelium in response to chronic acid exposure.

Why this is the key complication

  • Barrett esophagus is a premalignant condition that increases risk of esophageal adenocarcinoma.
  • The classic progression you should have in your head:
    • GERD → Barrett (intestinal metaplasia) → dysplasia → adenocarcinoma
  • Most adenocarcinomas arise in the distal esophagus (near the GE junction), matching the typical Barrett location.

High-yield associations (USMLE-style)

  • Risk factors for Barrett/adenocarcinoma:
    • Chronic GERD
    • Obesity
    • Male sex
    • White race
    • Smoking
  • Endoscopic clue: “Salmon-colored” tongues of mucosa extending upward from GE junction
  • Histology clue: goblet cells = intestinal metaplasia (the money phrase)

Why Every Other Answer Choice Is Wrong (and what it’s trying to test)

A. Squamous cell carcinoma of the esophagus

Why it’s tempting: “Cancer of the esophagus” is true, but wrong type.

High-yield distinction:

  • Squamous cell carcinoma is linked to:
    • Alcohol
    • Tobacco
    • Very hot beverages
    • Achalasia
    • Plummer-Vinson syndrome
  • More common in the mid-esophagus (classically), and worldwide is historically the most common type.

Barrett specifically increases risk of: adenocarcinoma, not squamous cell carcinoma.


C. Esophageal varices

Why it’s tempting: Students see “esophagus” + serious bleeding and jump to varices.

Reality check:

  • Varices result from portal hypertension, usually due to cirrhosis.
  • They occur at the lower esophagus due to porto-systemic anastomoses (left gastric vein ↔ azygos system).

This vignette has no portal HTN clues:

  • No cirrhosis stigmata (jaundice, ascites, spider angiomas)
  • No hematemesis/melena
  • Endoscopy description is classic for Barrett, not varices (varices look like dilated submucosal veins)

D. Mallory-Weiss tear

Why it’s tempting: Another common esophageal bleeding entity.

What it actually is:

  • A mucosal laceration at the gastroesophageal junction from forceful vomiting/retching
  • Presents with hematemesis after repeated vomiting
  • Common associations: alcohol binge, bulimia, gastroenteritis

Why it doesn’t fit:

  • Barrett is about chronic reflux and metaplasia, not acute vomiting-induced mucosal tears.

E. Achalasia due to loss of myenteric plexus neurons

Why it’s tempting: Dysphagia is in the stem.

But the mechanism and symptoms differ:

  • Achalasia = failure of LES relaxation + loss of peristalsis due to degeneration of Auerbach (myenteric) plexus
  • Dysphagia to solids and liquids from the start (not just solids)
  • Barium swallow: bird-beak appearance
  • Complication: increased risk of squamous cell carcinoma, not Barrett-type adenocarcinoma

In this stem:

  • Chronic heartburn + regurgitation + endoscopic Barrett findings → this is GERD → Barrett, not achalasia.

“Dysphagia” in Barrett/GERD: A subtle board-style point

The stem includes intermittent dysphagia to solids, which can signal:

  • Peptic stricture from chronic GERD (benign narrowing)
  • Or a red flag for malignancy if progressive + weight loss

Boards like to see whether you:

  • Recognize GERD/Barrett as the primary diagnosis, and
  • Don’t prematurely switch diagnoses just because “dysphagia” appears

Mini-Table: Quick Differentiation (High Yield)

ConditionKey risk factorsHallmark clueMain complication tested
Barrett esophagusChronic GERD, obesity, male, smokingSalmon mucosa + goblet cellsAdenocarcinoma
Esophageal adenocarcinomaBarrett, GERDDistal esophagus massProgressive dysphagia, weight loss
Esophageal SCCAlcohol, smoking, hot beverages, achalasiaClassically mid-esophagusLocal invasion, metastasis
VaricesCirrhosis/portal HTNMassive painless hematemesisExsanguination risk
Mallory-WeissRetching/vomitingHematemesis after vomitingUsually self-limited bleeding
AchalasiaIdiopathic, ChagasBird-beak, dysphagia solids + liquidsAspiration, SCC risk

USMLE Management Pearls You’re Expected to Know

Even when the question is about complications, Step writers love management-adjacent details.

For GERD symptoms

  • Lifestyle: weight loss, elevate head of bed, avoid late meals, trigger foods
  • Medications: PPIs are first-line for frequent symptoms

For Barrett esophagus

  • Confirm with endoscopy + biopsy (must show intestinal metaplasia with goblet cells)
  • Surveillance endoscopy depending on dysplasia status (broad concept > exact intervals for Step)
  • If high-grade dysplasia: endoscopic eradication therapy (e.g., radiofrequency ablation, endoscopic mucosal resection)
  • PPI therapy is commonly used to reduce acid exposure

Test-taking anchor: Barrett = metaplasia due to reflux; the big fear is adenocarcinoma.


Rapid-Fire Takeaways (What to remember on exam day)

  • Barrett = intestinal metaplasia (goblet cells) in distal esophagus due to GERD.
  • The major long-term risk is esophageal adenocarcinoma.
  • SCC is linked to alcohol/tobacco/hot liquids/achalasia, not Barrett.
  • Varices = portal HTN; Mallory-Weiss = retching; Achalasia = dysphagia to solids + liquids and bird-beak.